Anzeige
Mehr »
Login
Montag, 07.10.2024 Börsentäglich über 12.000 News von 690 internationalen Medien
Warum diese Aktie eine der besten Rohstoffanlagen für 2024 sein könnte...
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
484 Leser
Artikel bewerten:
(2)

Gleason & Sons LLC: Principal of Major U.S. Precious Metals Firm Assumes 19.9% Stake in Electric Royalties

CHARLOTTE, NC / ACCESSWIRE / April 10, 2023 / Stefan Gleason (the "Acquiror" or "Gleason") today announced that he is filing an early warning report in connection with his acquisition on the open market of additional shares of Electric Royalties Ltd. (TSXV:ELEC)(OTCQB:ELECF) ("Electric Royalties" or the "Company").

The Acquirer now beneficially owns or has control or direction over approximately 19.95% of the Company's issued and outstanding shares (on an as converted and partially diluted basis).

Stefan Gleason is a Charlotte-based entrepreneur who owns and leads several privately held businesses in the United States, including Money Metals Exchange LLC. Money Metals is one of the largest precious metals dealers and depositories in North America with 500,000 customers and approximately $1 billion in annual revenues.

"Electric Royalties already holds 21 royalties and several options across its nine target battery metals, with two royalties currently in production, one expected to begin production this quarter, and additional assets expected to begin producing cash flow in 2023 and 2024," said Gleason.

"I believe Electric Royalties offers an extremely compelling value proposition at its current market capitalization, as confirmed by independent analyst coverage. As the Company noted last week, roughly $520 million is being invested to advance these royalty assets at no cost to Electric Royalties, and I am confident the Company's management team can add additional cash-flowing royalties to the portfolio without issuing new shares," Gleason continued.

To that end, the Acquiror's family office, Gleason & Sons LLC, announced on January 25 it closed on a non-dilutive credit facility with an initial loan limit of C$2,000,000 to fund the Company's acquisition of new producing royalties, with additional credit capacity available to the Company if requested.

On April 6, 2023, Acquiror purchased 580,400 Company shares via the OTCQB (at a cost of C$220,552, or an average of $0.38 per share). Prior to April 6, the Acquiror held an aggregate of 17,791,633 Common Shares and 500,000 Warrant Shares, representing 19.335% of the issued and outstanding Shares on an as converted and partially diluted basis. After the purchases on April 6, the Acquiror held 18,372,033 Common Shares and 500,000 Warrant shares, or 19.949% of the issued and outstanding Shares on an as converted and partially diluted basis.

On December 5, 2022, the Acquiror previously filed a report under the early warning reporting rules of Canadian securities laws, disclosing that he beneficially owned or had control or direction over 16,011,593 Common Shares and 500,000 Warrant shares, at the time representing 17.547% of the Company's issued and outstanding Shares on an as converted and partially diluted basis. The Acquiror is filing this latest early warning report because he has now accumulated more than 2% of the Company's issued and outstanding Shares since his prior filing on December 5, 2022.

This early warning news release is issued under the early warning provisions of Canadian securities legislation, including National Instrument 62-104 - Take-Over Bids and Issuer Bids and National Instrument 62-103 - The Early Warning System and Related Take-Over Bid and Insider Reporting Issues. A copy of the Early Warning Report will be filed at www.sedar.com.

For further information, contact:
Stefan Gleason
Gleason & Sons LLC
15720 Brixham Hill Avenue, #205
Charlotte, NC 28277
Tel: 208-577-2230
Email: Stefan.Gleason@GleasonSons.com
http://www.gleasonsons.com/

This release includes certain statements that may be deemed "forward-looking statements." All statements in this release, other than statements of historical facts, that address anticipated future events are forward-looking statements. Although the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in the forward-looking statements.

SOURCE: Gleason & Sons LLC

View source version on accesswire.com:
https://www.accesswire.com/748123/Principal-of-Major-US-Precious-Metals-Firm-Assumes-199-Stake-in-Electric-Royalties

© 2023 ACCESSWIRE
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.